NASDAQ:VRAY - Viewray Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$6.99 +0.02 (+0.29 %)
(As of 05/27/2018 10:08 AM ET)
Previous Close$6.99
Today's Range$6.89 - $7.08
52-Week Range$4.40 - $10.64
Volume373,536 shs
Average Volume613,426 shs
Market Capitalization$501.49 million
P/E RatioN/A
Dividend YieldN/A
Beta0.59

About Viewray (NASDAQ:VRAY)

Viewray logoViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company's software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian delivers radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian provides real-time imaging that defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription between fractions as needed.

Receive VRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for VRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VRAY
CUSIPN/A
Phone440-703-3210

Debt

Debt-to-Equity Ratio0.77
Current Ratio3.79
Quick Ratio3.04

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$34.04 million
Price / Sales14.73
Cash FlowN/A
Price / CashN/A
Book Value$0.80 per share
Price / Book8.74

Profitability

EPS (Most Recent Fiscal Year)($1.04)
Net Income$-72,170,000.00
Net Margins-83.09%
Return on Equity-1,375.57%
Return on Assets-44.36%

Miscellaneous

Employees139
Outstanding Shares71,740,000

Viewray (NASDAQ:VRAY) Frequently Asked Questions

What is Viewray's stock symbol?

Viewray trades on the NASDAQ under the ticker symbol "VRAY."

How were Viewray's earnings last quarter?

Viewray Inc (NASDAQ:VRAY) posted its quarterly earnings data on Thursday, May, 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.20) by $0.09. The company earned $26.19 million during the quarter, compared to analyst estimates of $15.50 million. Viewray had a negative return on equity of 1,375.57% and a negative net margin of 83.09%. The firm's quarterly revenue was up 2029.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.54) earnings per share. View Viewray's Earnings History.

What price target have analysts set for VRAY?

5 Wall Street analysts have issued twelve-month target prices for Viewray's shares. Their forecasts range from $10.00 to $13.50. On average, they anticipate Viewray's stock price to reach $11.90 in the next twelve months. View Analyst Ratings for Viewray.

What are Wall Street analysts saying about Viewray stock?

Here are some recent quotes from research analysts about Viewray stock:
  • 1. Cantor Fitzgerald analysts commented, "Strong 1Q results. VRAY reported $26.2MM of revenue in 1Q, beating Street expectations by $13.1MM. Revenue was higher than expected due to delayed revenue recognition of a system installed in 4Q, earlier-than-expected recognition from an installation in late-1Q, and a system upgrade from the previous generation MRIdian Cobalt. VRAY placed four systems and upgraded one, which was in line with our expectations. VRAY received gross orders of $21MM, slightly below our expectation of $24MM. The backlog at the end of the quarter was $195MM, down slightly from $204MM last quarter." (5/11/2018)
  • 2. Mizuho analysts commented, "We were at the Advanced Applications of MR-Guided Radiotherapy Symposium in Amsterdam on March 16th, 2018. The event was very well attended with approximately 200 people; most were potential customers who showed strong interest in ViewRay’s MRIdian. We highlight our key takeaways from the conference and additional insights into the MRI Linac below. Overall, we maintain our view that ViewRay has leadership in real time imaging guided LINAC today." (4/19/2018)

Who are some of Viewray's key competitors?

When did Viewray IPO?

(VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Has Viewray been receiving favorable news coverage?

Headlines about VRAY stock have been trending somewhat positive on Sunday, Accern Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Viewray earned a media sentiment score of 0.07 on Accern's scale. They also gave news stories about the company an impact score of 47.24 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Viewray's major shareholders?

Viewray's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Fosun International Ltd (15.01%), Park West Asset Management LLC (4.80%), BlackRock Inc. (2.59%), Acuta Capital Partners LLC (2.58%), Next Century Growth Investors LLC (0.80%) and Russell Investments Group Ltd. (0.57%). Company insiders that own Viewray stock include Aditya Puri, Ajay Bansal, David P Bonita, Fmr Llc, Henry A Mckinnell and James F Dempsey. View Institutional Ownership Trends for Viewray.

Which institutional investors are selling Viewray stock?

VRAY stock was sold by a variety of institutional investors in the last quarter, including Acuta Capital Partners LLC, Next Century Growth Investors LLC, Alpine Woods Capital Investors LLC and A.R.T. Advisors LLC. View Insider Buying and Selling for Viewray.

Which institutional investors are buying Viewray stock?

VRAY stock was acquired by a variety of institutional investors in the last quarter, including Fosun International Ltd, Park West Asset Management LLC, Millennium Management LLC, Thompson Siegel & Walmsley LLC, UBS Group AG, Russell Investments Group Ltd., Barclays PLC and Schwab Charles Investment Management Inc.. Company insiders that have bought Viewray stock in the last two years include Aditya Puri, Ajay Bansal, David P Bonita and Henry A Mckinnell. View Insider Buying and Selling for Viewray.

How do I buy shares of Viewray?

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Viewray's stock price today?

One share of VRAY stock can currently be purchased for approximately $6.99.

How big of a company is Viewray?

Viewray has a market capitalization of $501.49 million and generates $34.04 million in revenue each year. The company earns $-72,170,000.00 in net income (profit) each year or ($1.04) on an earnings per share basis. Viewray employs 139 workers across the globe.

How can I contact Viewray?

Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected]


MarketBeat Community Rating for Viewray (VRAY)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  201
MarketBeat's community ratings are surveys of what our community members think about Viewray and other stocks. Vote "Outperform" if you believe VRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Viewray (NASDAQ:VRAY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Viewray in the last 12 months. Their average twelve-month price target is $11.90, suggesting that the stock has a possible upside of 70.24%. The high price target for VRAY is $13.50 and the low price target for VRAY is $10.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.90$11.5833$11.5833$10.60
Price Target Upside: 70.24% upside50.43% upside41.61% upside12.41% upside

Viewray (NASDAQ:VRAY) Consensus Price Target History

Price Target History for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ:VRAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/11/2018Cantor FitzgeraldReiterated RatingBuy$13.00HighView Rating Details
4/19/2018MizuhoReiterated RatingBuy$12.00HighView Rating Details
2/8/2018B. RileyInitiated CoverageBuy ➝ Buy$13.50LowView Rating Details
11/17/2017Northland SecuritiesReiterated RatingBuy$10.00N/AView Rating Details
7/22/2017AegisReiterated RatingBuy$11.00HighView Rating Details
5/17/2017BTIG ResearchReiterated RatingBuy$10.00MediumView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Viewray (NASDAQ:VRAY) Earnings History and Estimates Chart

Earnings by Quarter for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ:VRAY) Earnings Estimates

2018 EPS Consensus Estimate: ($0.79)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.24)($0.21)($0.23)
Q2 20182($0.21)($0.21)($0.21)
Q3 20182($0.19)($0.18)($0.19)
Q4 20182($0.17)($0.17)($0.17)

Viewray (NASDAQ VRAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2018Q1 2018($0.20)($0.11)$15.50 million$26.19 millionViewN/AView Earnings Details
3/12/2018Q4 2017($0.25)($0.38)$21.23 million$19.90 millionViewListenView Earnings Details
11/13/2017Q3 2017($0.12)($0.19)$18.63 million$12.20 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.24)($0.26)$0.68 million$0.70 millionViewListenView Earnings Details
5/15/2017Q1 2017($0.22)($0.24)$0.52 million$1.23 millionViewN/AView Earnings Details
3/16/2017Q4 2016($0.34)($0.25)$13.65 million$16.13 millionViewN/AView Earnings Details
11/14/2016Q316($0.27)($0.35)$0.39 million$0.36 millionViewN/AView Earnings Details
8/15/2016Q216($0.29)($0.32)$5.53 million$0.30 millionViewListenView Earnings Details
5/13/2016Q116($0.30)($0.35)$5.50 million$5.50 millionViewN/AView Earnings Details
3/28/2016Q4 2015($0.37)$4.61 millionViewN/AView Earnings Details
11/9/2015Q3 2015($0.35)$5.32 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Viewray (NASDAQ:VRAY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Viewray (NASDAQ VRAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 62.81%
Institutional Ownership Percentage: 83.35%
Insider Trading History for Viewray (NASDAQ:VRAY)
Institutional Ownership by Quarter for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ VRAY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2018James F DempseyInsiderSell75,243$7.57$569,589.51View SEC Filing  
4/25/2017Fmr LlcInsiderSell106,781$6.76$721,839.56View SEC Filing  
4/24/2017Fmr LlcInsiderSell101,139$6.71$678,642.69View SEC Filing  
4/20/2017Fmr LlcInsiderSell101,236$6.90$698,528.40View SEC Filing  
4/18/2017Fmr LlcInsiderSell107,217$7.24$776,251.08View SEC Filing  
4/13/2017Fmr LlcInsiderSell115,860$7.44$861,998.40View SEC Filing  
4/12/2017Fmr LlcInsiderSell179,494$7.40$1,328,255.60View SEC Filing  
4/10/2017Fmr LlcInsiderSell178,556$7.77$1,387,380.12View SEC Filing  
4/7/2017Fmr LlcInsiderSell52,050$7.89$410,674.50View SEC Filing  
4/5/2017Fmr LlcInsiderSell196,397$7.90$1,551,536.30View SEC Filing  
4/3/2017Fmr LlcInsiderSell217,883$8.29$1,806,250.07View SEC Filing  
3/30/2017Fmr LlcInsiderSell28,661$8.46$242,472.06View SEC Filing  
1/18/2017Ajay BansalCFOBuy62,597$3.17$198,432.4970,104View SEC Filing  
1/18/2017Henry A. MckinnellDirectorBuy312,989$3.17$992,175.13View SEC Filing  
9/9/2016Aditya PuriDirectorBuy1,472,803$2.95$4,344,768.8518,964View SEC Filing  
8/22/2016David P BonitaDirectorBuy1,138,074$2.95$3,357,318.30View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Viewray (NASDAQ VRAY) News Headlines

Source:
DateHeadline
FY2018 EPS Estimates for Viewray Inc Increased by Cantor Fitzgerald (VRAY)FY2018 EPS Estimates for Viewray Inc Increased by Cantor Fitzgerald (VRAY)
www.americanbankingnews.com - May 24 at 8:32 AM
World-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy SymposiumWorld-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy Symposium
finance.yahoo.com - May 23 at 5:44 PM
Viewray Inc (VRAY) Receives Consensus Recommendation of "Buy" from AnalystsViewray Inc (VRAY) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 21 at 8:50 AM
FY2018 EPS Estimates for Viewray Inc (VRAY) Boosted by Zacks Investment ResearchFY2018 EPS Estimates for Viewray Inc (VRAY) Boosted by Zacks Investment Research
www.americanbankingnews.com - May 21 at 1:24 AM
Viewray (VRAY) Downgraded by BidaskClubViewray (VRAY) Downgraded by BidaskClub
www.americanbankingnews.com - May 17 at 5:47 PM
ViewRay to Present at the UBS Global Healthcare ConferenceViewRay to Present at the UBS Global Healthcare Conference
finance.yahoo.com - May 16 at 5:51 PM
Viewray Target of Unusually Large Options Trading (VRAY)Viewray Target of Unusually Large Options Trading (VRAY)
www.americanbankingnews.com - May 15 at 6:58 AM
Traders Buy High Volume of Viewray Put Options (VRAY)Traders Buy High Volume of Viewray Put Options (VRAY)
www.americanbankingnews.com - May 15 at 6:48 AM
Critical Review: AxoGen (AXGN) and Viewray (VRAY)Critical Review: AxoGen (AXGN) and Viewray (VRAY)
www.americanbankingnews.com - May 14 at 1:33 PM
Viewray (VRAY) versus BioSig Technologies (BSGM) Financial AnalysisViewray (VRAY) versus BioSig Technologies (BSGM) Financial Analysis
www.americanbankingnews.com - May 13 at 3:15 AM
 Brokerages Expect Viewray Inc (VRAY) Will Post Quarterly Sales of $16.31 Million Brokerages Expect Viewray Inc (VRAY) Will Post Quarterly Sales of $16.31 Million
www.americanbankingnews.com - May 12 at 2:57 AM
BRIEF-ViewRay Files Certificate Of Elimination Of Series A Convertible Preferred Stock With Delaware Secretary Of StateBRIEF-ViewRay Files Certificate Of Elimination Of Series A Convertible Preferred Stock With Delaware Secretary Of State
www.reuters.com - May 11 at 6:27 PM
BRIEF-ViewRay Q1 Loss Per Share $0.11BRIEF-ViewRay Q1 Loss Per Share $0.11
www.reuters.com - May 11 at 6:27 PM
Viewray (VRAY) Releases  Earnings Results, Beats Expectations By $0.09 EPSViewray (VRAY) Releases Earnings Results, Beats Expectations By $0.09 EPS
www.americanbankingnews.com - May 11 at 4:37 PM
Viewray (VRAY) Receives "Buy" Rating from Cantor FitzgeraldViewray (VRAY) Receives "Buy" Rating from Cantor Fitzgerald
www.americanbankingnews.com - May 11 at 3:56 PM
After-Hours Stock Movers 05/10: (KGJI) (TTD) (VRAY) Higher; (SYMC) (RDFN) (NVDA) Lower (more...)After-Hours Stock Movers 05/10: (KGJI) (TTD) (VRAY) Higher; (SYMC) (RDFN) (NVDA) Lower (more...)
www.streetinsider.com - May 11 at 8:51 AM
ViewRay beats by $0.09, beats on revenueViewRay beats by $0.09, beats on revenue
seekingalpha.com - May 11 at 8:51 AM
ViewRay (VRAY) Tops Q1 EPS by 8c, Beats on Revenues; Offers FY18 Revenue Outlook Above ConsensusViewRay (VRAY) Tops Q1 EPS by 8c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
www.streetinsider.com - May 11 at 8:51 AM
ViewRay files for $150M mixed shelf offeringViewRay files for $150M mixed shelf offering
seekingalpha.com - May 11 at 8:51 AM
Edited Transcript of VRAY earnings conference call or presentation 10-May-18 8:30pm GMTEdited Transcript of VRAY earnings conference call or presentation 10-May-18 8:30pm GMT
finance.yahoo.com - May 11 at 8:50 AM
ViewRay: 1Q Earnings SnapshotViewRay: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 5:40 PM
ViewRay Reports First Quarter 2018 Financial ResultsViewRay Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 10 at 5:40 PM
 Brokerages Expect Viewray Inc (VRAY) Will Post Earnings of -$0.22 Per Share Brokerages Expect Viewray Inc (VRAY) Will Post Earnings of -$0.22 Per Share
www.americanbankingnews.com - May 10 at 3:06 PM
ViewRay Announces Conference Call and Webcast of First Quarter 2018 Financial Results to be Held After Market on May 10, 2018ViewRay Announces Conference Call and Webcast of First Quarter 2018 Financial Results to be Held After Market on May 10, 2018
finance.yahoo.com - May 7 at 5:44 PM
ViewRays Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development ...ViewRay's Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development ...
www.prnewswire.com - May 2 at 5:38 PM
ViewRays Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided RadiotherapyViewRay's Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided Radiotherapy
finance.yahoo.com - May 2 at 5:38 PM
Viewray (VRAY) Raised to "Hold" at ValuEngineViewray (VRAY) Raised to "Hold" at ValuEngine
www.americanbankingnews.com - May 2 at 2:02 PM
Miami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRays MRIdian® LinacMiami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRay's MRIdian® Linac
finance.yahoo.com - May 1 at 5:31 PM
Miami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients ...Miami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients ...
www.prnewswire.com - April 30 at 9:21 AM
Viewray Inc (VRAY) Receives Average Rating of "Buy" from AnalystsViewray Inc (VRAY) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - April 26 at 9:52 AM
$15.50 Million in Sales Expected for Viewray Inc (VRAY) This Quarter$15.50 Million in Sales Expected for Viewray Inc (VRAY) This Quarter
www.americanbankingnews.com - April 25 at 4:52 AM
Zacks: Brokerages Anticipate Viewray Inc (VRAY) Will Post Earnings of -$0.22 Per ShareZacks: Brokerages Anticipate Viewray Inc (VRAY) Will Post Earnings of -$0.22 Per Share
www.americanbankingnews.com - April 23 at 5:12 AM
Reviewing Viewray (VRAY) and Zynex (ZYXI)Reviewing Viewray (VRAY) and Zynex (ZYXI)
www.americanbankingnews.com - April 22 at 7:26 AM
VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR ...VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR ...
www.prnewswire.com - April 19 at 5:57 PM
Viewrays (VRAY) Buy Rating Reaffirmed at MizuhoViewray's (VRAY) Buy Rating Reaffirmed at Mizuho
www.americanbankingnews.com - April 19 at 6:50 AM
ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided RadiotherapyViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
finance.yahoo.com - April 18 at 5:38 PM
Viewray (VRAY) Upgraded to "Sell" by BidaskClubViewray (VRAY) Upgraded to "Sell" by BidaskClub
www.americanbankingnews.com - April 13 at 9:39 AM
Trimedyne (TMED) versus Viewray (VRAY) Financial ContrastTrimedyne (TMED) versus Viewray (VRAY) Financial Contrast
www.americanbankingnews.com - April 10 at 9:14 PM
Viewray Inc (VRAY) Expected to Post Quarterly Sales of $15.50 MillionViewray Inc (VRAY) Expected to Post Quarterly Sales of $15.50 Million
www.americanbankingnews.com - April 8 at 4:31 AM
-$0.22 Earnings Per Share Expected for Viewray Inc (VRAY) This Quarter-$0.22 Earnings Per Share Expected for Viewray Inc (VRAY) This Quarter
www.americanbankingnews.com - April 6 at 9:01 AM
Mizuho Reiterates "Buy" Rating for Viewray (VRAY)Mizuho Reiterates "Buy" Rating for Viewray (VRAY)
www.americanbankingnews.com - April 5 at 12:39 PM
University Clinic Heidelberg Completes Installation and Commissioning of ViewRays MRIdian MR Image-Guided ...University Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided ...
www.prnewswire.com - April 4 at 4:32 PM
University Clinic Heidelberg Completes Installation and Commissioning of ViewRays MRIdian MR Image-Guided Radiotherapy LinacUniversity Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac
finance.yahoo.com - April 4 at 4:32 PM
Technical Perspectives on Medical Equipment Stocks -- Smith & Nephew, Stryker, ViewRay, and Zimmer BiometTechnical Perspectives on Medical Equipment Stocks -- Smith & Nephew, Stryker, ViewRay, and Zimmer Biomet
www.prnewswire.com - April 2 at 8:54 AM
Viewray Inc (VRAY) Given Average Recommendation of "Buy" by BrokeragesViewray Inc (VRAY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 1 at 8:03 AM
Viewray (VRAY) PT Set at $13.00 by Cantor FitzgeraldViewray (VRAY) PT Set at $13.00 by Cantor Fitzgerald
www.americanbankingnews.com - March 30 at 12:35 PM
Viewrays (VRAY) "Buy" Rating Reiterated at MizuhoViewray's (VRAY) "Buy" Rating Reiterated at Mizuho
www.americanbankingnews.com - March 29 at 10:16 PM
BidaskClub Lowers Viewray (VRAY) to HoldBidaskClub Lowers Viewray (VRAY) to Hold
www.americanbankingnews.com - March 29 at 3:00 PM
Viewray (VRAY) Lowered to Strong Sell at BidaskClubViewray (VRAY) Lowered to Strong Sell at BidaskClub
www.americanbankingnews.com - March 28 at 8:05 AM
RAD Technology Medical Systems Purchases Two ViewRay MRIdian Linac SystemsRAD Technology Medical Systems Purchases Two ViewRay MRIdian Linac Systems
www.prnewswire.com - March 27 at 5:30 PM

SEC Filings

Viewray (NASDAQ:VRAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Viewray (NASDAQ VRAY) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.